Gunn & Company Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Gunn & Company Investment Management's LLY Position: Q3 2024 in Review
Gunn & Company Investment Management reduced its Eli Lilly (LLY) stake by 46% in Q3 2024, selling an estimated $628K and leaving 835 shares worth $740K. The position accounts for 0.51% of the portfolio, ranked #41.
Gunn & Company Investment Management first reported a position in LLY in Q3 2023 and has held it in 5 quarters since. The position peaked at $1.39M in Q2 2024. 3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Gunn & Company Investment Management held 835 shares of Eli Lilly worth $740K as of Q3 2024.
- Gunn & Company Investment Management sold 699 Eli Lilly shares in Q3 2024, an estimated $628K.
- Eli Lilly made up 0.51% of Gunn & Company Investment Management's portfolio in Q3 2024, its #41 holding.
- Gunn & Company Investment Management first reported a position in Eli Lilly in Q3 2023 and has held it in 5 quarters since.
- Gunn & Company Investment Management's Eli Lilly position peaked at $1.39M in Q2 2024.
- 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Gunn & Company Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.